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The most important development in head and neck oncology
of the past decade is the demonstration that patients with human
papillomavirus (HPV)-mediated oropharyngeal cancers have
significantly improved outcomes, compared to HPV-negative
counterpart patients.
We examined racial disparities among 102 oropharyngeal car-
cinoma (OPC) patients (30 African Americans, 72 Whites) compar-
ing the present of HPV16/18 E6 and E7 oncoproteins, and
p16Ink4A overexpression, with times to disease progression (DP)
and disease specific survival (DSS). Expression of HPV16/18 tran-
scripts was assessed by reverse transcription and polymerase
chain reaction using type-specific E6/E7 primers; p16Ink4A was
evaluated by immunohistochemistry. African Americans were
significantly more likely to present with high T stage disease
and receive nonsurgical treatment. HPV16/18 was present in
63% of patients; no racial differences were observed. Silenced
p16Ink4A in OPC was significantly more common in African
Americans (15/24) than Whites (20/69) (p = 0.004), and HPV16
+ African Americans (6/24) than HPV +Whites (2/42) (p = 0.023).
Kaplan Meier analysis for DSS revealed a protective effect for
p16Ink4A overexpression (p = 0.0028), HPV16+ (p = 0.036), and
Whites (p = 0.0039). Shorter DSS was associated with primary
definitive chemoradiation (p = 0.019) and T3/T4 disease
(p = 0.0001). A protective effect with respect to disease progres-
sion was observed for HPV16+ (p = 0.007), Whites (p = 0.0006)
and p16Ink4A overexpression (p = 0.0001). African Americans
with OPC experience poorer outcomes likely due to p16Ink4A
silencing, higher T stage, and nonsurgical treatment, but not
lower rates of transcriptionally active HPV16/18.
We studied patients with oral cavity squamous cell carcinoma
for HPV16 and HPV18, local immune response, p16 expression
and outcome.
Overexpression of p16INK4a was uncommon in oral cavity
squamous cell carcinoma (17/112 or 15.2%). HPV16 and HPV18
were detected in 22.6% and 11% patients respectively. We demon-
strated that the presence of transcriptionally active HPV16 in oral
cavity squamous cell carcinomas does not correlate with
p16INK4a overexpression, enhanced local tumor immunity, or
improved outcome. To investigate the possible mechanism of pro-
tective effect of HPV and p16INK4a, we have developed primary
cancer cell lines from resections with known patterns of invasion.
Given that cell lines derived from HPV-mediated oropharyngeal
squamous cell carcinomas are less invasive than their
HPV-negative counterparts, we tested the hypothesis that viral
oncoproteins E6, E7, and p16INK4a can affect tumor invasion.
We demonstrated that p16INK4a overexpression in two cancer
cell lines (UAB-3 and UAB-4), derived from oral cavity squamous
cell carcinomas with the most aggressive invasive phenotype,
dramatically decrease tumor invasiveness by altering expression
of extracellular matrix remodeling genes. Pathway analysis
integrating changes in RNA expression and kinase activities
reveals different potential p16INK4a-sensitive pathways. In
summary, we presented clinical data from a large cohort of head
and neck squamous cell carcinoma patients with respect to
transcriptionally active HPV16, p16INK4a overexpression, local
adaptive tumor immunity, and outcome. Observed differences
in clinical outcomes could be perhaps due to differential
immune responses and gene activation profile. The detection of
a HPV-positivity in HNSCC has important clinical implications
as independent prognostic factor for treatment deintensification
and improved survival of HPV-mediated oropharyngeal cancers.
In our knowledge the further studies are needed to dissect
the HPV-positive HNSCC in more detail to find the effective
prognostic markers as well as molecular targets to affect tumor
behavior.
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Background: Alveolar macrophages (AM) are pulmonary resi-
dents of the bone marrow-derived mononuclear phagocyte sys-
tem that play a critical role in several diverse lung functions
and in lung host defense. The role of AM in lung cancer is multi-
faceted. AM secretion of proinflammatory cytokines has been
found to enhance antitumor functions, cytostasis and cytotoxic-
ity. AM have also demonstrated to have protumor functions
resulting in tumor progression.
Materials and methods: 24-week-old male A/f mice were kept
in plastic cages under standard laboratory conditions and
received food and water ad libitum. Animals were randomly
assigned to the following experimental groups: I – control,
II – radiation only, III – sulphur dioxide only, IV – sulphur
dioxide + radiation. Animals were subjected to total irradiation
at dose 1.0 Gy (dose density of 16.6 cGy/min, using a 60Co gamma
equipment). After irradiation mice were inhaled air with sulphur
dioxide (20 mg/m3 for 1 h) in separate exposure chamber.
At the 20th week of experiment the 20 mice per each group
were subjected to autopsy. Excised lungs were fixed in neutral
buffered 10% formalin. To obtain an index of tumor incidence,
the percentage of tumor – bearing mice per total number of mice
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in each group was calculated. Tumor multiplicity was defined as
the average number of tumors per mice, obtained by dividing
the total number of tumors by the total number of mice per group,
including non-tumor bearing animals.
Bronchoalveolar lavage (BAL) of lungs was performed on 6
mice (animals were anesthetized by an ip injection of sodium
thiopental) from each study group at the 1, 7, 15 and 30 days after
irradiation and SO2 inhalation. Total cells of BAL were counted
using hemocytometer chamber and an optical microscope with
a 400 zoom. BAL differential cell (macrophages, lymphocytes,
eosinophiles and neutrophils) counts were performed on slides
(Romanowsky stain). Phagocytic activity of AM was counted on
slides. AM morphometric study was done by measuring the area
of each cell (square of cell) and the area of nuclear of each cell
(square of nuclear) with use of the original image analyzer com-
puter system.
Results: Results of the combined effects of radiation and
inhalation of sulfur dioxide showed the growth of tumor quantity
in the lung: the frequency of adenomas/mouse was more than
42% higher than that of control group. Synergism coefficient
was 1.1 in this case.
Irradiation at a dose of 1.0 Gymodifies the reaction of free cells
of lung on the action of sulfur dioxide, which is manifested in the
change of the number of cells in the BAL fluid, the phagocytic
activity of the AM, as well as of the changes the morphometric
parameters of their cells.
Conclusion: Thus, if the amount of radiation exposure of BAL
cells was significantly reduced by the 1st and 7th days, and after
inhalation of sulfur dioxide – tended to increase, then the com-
bined action on the 7th day it was almost half the theoretical
(hypothetical) the sum of the separate effects of the studied fac-
tors. Exposure to sulfur dioxide significantly slowed the activation
of cell count. It was found, that after combined action of the
investigated factors the morphological characteristics of macro-
phages (reducing the square of cells and their nuclei) have
changed (7th and 15th day). The absorption activity of phagocytes
was significantly reduced (7 day).
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Background: Despite the abundance of theoretical evidences
displaying the considerable role of the ‘‘soil” in metastasis
progression, the majority of cancer research and cancer therapy
pathogenetic methods focused mainly on the tumor cells. There
is still no clear clinical data showing the role of ‘‘soil” in the
metastasis. Identification of factors and mechanisms driving
the conditions promoting tumor dissemination may lead to
therapeutic strategy to detect and prevent metastases at the
earliest step. It has been established that bone marrow-derived
hematopoietic progenitor cells home to pre-metastatic sites
before tumor cells infiltrate in these sites. These hematopoietic
progenitor cells form regulatory cell cluster of stromal microenvi-
ronment (premetastatic niche) to promote secondary tumor
growth. In this context, the aim of our study was to evaluate
the level of different pools of circulating tumor cells and bone
marrow progenitor cells in the blood of patients with breast
cancer in the dynamics of neoadjuvant chemotherapy.
Materials and methods: Patients (prospective study) with
newly diagnosed invasive breast cancer in the age range 18–50
years and tumor volume of 2.0(> or =) cm, referred at the Tomsk
Cancer Research Institute for treatment were included into the
study. Eligibility criteria were as follows: the patient’s informed
consent to participate in research; morphologically verified diag-
nosis of invasive carcinoma of non-specific type; luminal B-1, -2,
triple negative (basal-like subtype included), HER2 positive breast
cancer; T2-4N0-3M0; preserved menstrual function; satisfactory
performance status (on a scale (< or =) ECOG 2). Exclusion Criteria
were: other than luminal histological type of breast cancer,
multiple primary cancer; chronic inflammatory diseases in the
acute stage. Samples of venous blood taken from breast cancer
patients before biopsy, after biopsy and after each subsequent
course of neoadjuvant chemotherapy (NACHT) were served as a
study material. The various pools of circulating tumor cells and
bone-marrow derived progenitor cells were determined using
monoclonal antibodies to EpCam, CD44, CD45, CD24,
N-cadherin, CD34, CD133, CD202, VEGFR1 and CD90, labeled with
different fluorochromes on flow cytometry BD FACSCanto TM II.
Results: The study showed that each succeeding course of
NACHT increased blood levels of circulating tumor cells, and bone
marrow progenitor cells with a phenotype characteristic of EPC
(endothelial progenitor cells) (CD34 + CD45–VEGFR + CD133
+ CD202 +) and MSC (mesenchymal progenitor stem cells
fibroblasts) (CD34–CD90 + VEGFR1–CD45–CD202–). Influence of
the NACHT on hematopoietic stem cells HSC (VEGFR1 + CD34 +
CD45lowSD202–) and progenitor cells HPC – CD34 + CD45 +
CD90–VEGFR1 + CD133 – was ambiguous.
Conclusion: Neoadjuvant chemotherapy increases blood levels
of circulating tumor cells, endothelial progenitor cells and mes-
enchymal stem cells progenitor fibroblasts, thus promoting the
formation of premetastatic niche.
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